Cart
sales@molnova.com
2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid
CAS No. 1053228-28-6
2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid( —— )
Catalog No. M28768 CAS No. 1053228-28-6
2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid is a chemical agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid
-
NoteResearch use only, not for human use.
-
Brief Description2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid is a chemical agent.
-
Description2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid is a chemical agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1053228-28-6
-
Formula Weight222.45
-
Molecular FormulaC6H2Cl3N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1c[nH]c2nc(Cl)nc(Cl)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pei H, et al. Discovery of potent ureido tetrahydrocarbazole derivatives for cancer treatments through targeting tumor-associated macrophages. Eur J Med Chem. 2019 Dec 1;183:111741.
molnova catalog
related products
-
HS271
HS271 is a highly potent, orally active and selective IRAK4 inhibitor, with an IC50 of 7.2 μM. HS271 exhibits superior enzymatic and cellular activities, as well as excellent pharmacokinetic properties.
-
Opigolix
Opigolix, a Gonadotropin-releasing hormone receptor antagonist, treats hormone-dependent conditions by inhibiting the actions of gonadotropin-releasing hormone (GnRH).
-
MAO-B-IN-5
MAO-B-IN-5 is a potent, selective, and orally active MAO-B inhibitor with an IC50 of 0.204 μM, showing potential for research in Parkinson's disease (PD) .
